Bio­gen par­ing back re­search ef­forts; Will Chi­nese biotechs threat­en US dom­i­nance?; What the new ad­min­is­tra­tion means for phar­ma ; and more

Wel­come to the week­end! We saw a flur­ry of health-re­lat­ed news from Wash­ing­ton DC this week as the Trump ad­min­is­tra­tion of­fi­cial­ly be­gan its tran­si­tion. Let …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER